Living with Peripartum Cardiomyopathy: A Statement from the Heart Failure Association and the Association of Cardiovascular Nursing and Allied Professions of the European Society of Cardiology
Year: 2024
Type: article
Abstract: This statement focuses on the fact that women with peripartum cardiomyopathy (PPCM) have a substantial mortality and morbidity rate. Less than 50% of patients have full recovery of their cardiac function within 6 months of diagnosis. Also, patients with recovered cardiac function often suffer from comorbidities, such as hypertension or arrhythmias, which require long-term treatment. This has major implications which extend beyond the life of the patient, as it may also substantially impact her family. Women with a new diagnosis of PPCM should be involved in the decision-making processes regarding therapies, e.g. the recommendation to abstain from breastfeeding, or the use of cardiac implantable electronic devices. Women living with PPCM face the uncertainty of not knowing for some time whether their cardiac function will recover to allow them a near-to-normal life expectancy. This not only impacts their ability to work, which may have financial implications, but may also affect mental health and quality of life for the extended family. Women living with PPCM must be informed that a future pregnancy always carries a substantial risk and, in case of poor cardiac recovery, is associated with a high morbidity and mortality. Patients with PPCM are best managed by an interdisciplinary and multiprofessional approach including e.g. a cardiologist, a gynaecologist, nurses, a psychologist, and social workers. The scope of this document encompasses contemporary challenges and approaches for the management of women diagnosed with PPCM.
DOI: 10.1002/ejhf.3377
Authors: Karen Sliwa, Amina Rakisheva, Charle Viljoen, Tobias Pfeffer, Maggie Simpson, Alice M. Jackson, Mark C. Petrie, Peter van der Meer, Hasan Al Farhan, Silvana Jovanova, Amam Mbakwem, Gianfranco Sinagra, Emeline Van Craenenbroeck, Julian Hoevelmann, Mark R. Johnson, Richard Mindham, Ovidiu Chioncel, Kai G. Kahl, Giuseppe Rosano, Carsten Tschöpe, Alexandre Mebazaa, Petar Seferovic, Johann Bauersachs
Institutions: University of Cape Town, Medizinische Hochschule Hannover, Golden Jubilee National Hospital, University of Glasgow, University Medical Center Groningen, University of Baghdad, Iraqi Board for Medical Specializations, Ss. Cyril and Methodius University in Skopje, University of Lagos, University of Trieste, Azienda sanitaria universitaria Giuliano Isontina, Antwerp University Hospital, Universitätsklinikum des Saarlandes, University of London, St George's, University of London, Royal Brompton Hospital, Imperial College London, European Society of Cardiology, Carol Davila University of Medicine and Pharmacy, St George's Hospital, Berlin-Brandenburger Centrum für Regenerative Therapien, German Centre for Cardiovascular Research, Charité – Universitätsmedizin Berlin, Université Paris Cité, Assistance Publique – Hôpitaux de Paris, Hôpital Lariboisière, Hôpital Saint-Louis, Université Paris Diderot, University of Belgrade
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $5,250
Funder: Medical Research Council
OpenAlex ID: W4401428638
